Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. LIEBERMAN J; FABRY JA; FONG DM; PARKERSON GR
   RECOGNITION OF A SMALL NUMBER OF DIVERSE EPITOPES DOMINATES THE CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HIV TYPE-1 IN AN INFECTED INDIVIDUAL
   AIDS research and human retroviruses
   
   J. Lieberman et al., "RECOGNITION OF A SMALL NUMBER OF DIVERSE EPITOPES DOMINATES THE CYTOTOXIC T-LYMPHOCYTE RESPONSE TO HIV TYPE-1 IN AN INFECTED INDIVIDUAL", AIDS research and human retroviruses, 13(5), 1997, pp. 383-392
2. LIEBERMAN J; SKOLNIK PR; PARKERSON GR; FABRY JA; LANDRY B; BETHEL J; KAGAN J; ATKINS MB; GRADON J; STEIN D; VIRANIKETTER N; BANACH M; SCOTT M; MEYERS J; LEE E; STANDIFORD H; FONG DM; WANG A; BEYER D
   SAFETY OF AUTOLOGOUS, EX-VIVO EXPANDED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE INFUSION IN HIV-INFECTED PATIENTS
   Blood
   
   J. Lieberman et al., "SAFETY OF AUTOLOGOUS, EX-VIVO EXPANDED HUMAN-IMMUNODEFICIENCY-VIRUS (HIV)-SPECIFIC CYTOTOXIC T-LYMPHOCYTE INFUSION IN HIV-INFECTED PATIENTS", Blood, 90(6), 1997, pp. 2196-2206
3. SHANKAR P; FABRY JA; FONG DM; LIEBERMAN J
   3 REGIONS OF HIV-1 GP160 CONTAIN CLUSTERS OF IMMUNODOMINANT CTL EPITOPES
   Immunology letters
   
   P. Shankar et al., "3 REGIONS OF HIV-1 GP160 CONTAIN CLUSTERS OF IMMUNODOMINANT CTL EPITOPES", Immunology letters, 52(1), 1996, pp. 23-30
4. LIEBERMAN J; SKOLNIK PR; PARKERSON GR; FABRY JA; FONG DM; BEYER D; WANG A; LANDRY B
   IMMUNOTHERAPY WITH EX VIVO-EXPANDED HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN SUBJECTS WITH CD4 COUNTS OF 100-400 MM(3)/
   AIDS research and human retroviruses
   
   J. Lieberman et al., "IMMUNOTHERAPY WITH EX VIVO-EXPANDED HIV-SPECIFIC CYTOTOXIC T-LYMPHOCYTES IN SUBJECTS WITH CD4 COUNTS OF 100-400 MM(3)/", AIDS research and human retroviruses, 11, 1995, pp. 132-132